Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Assets (2020 - 2025)

Historic Return on Assets for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to 0.61%.

  • Pliant Therapeutics' Return on Assets fell 1700.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.46% for FY2024, which is 900.0% down from last year.
  • Latest data reveals that Pliant Therapeutics reported Return on Assets of 0.61% as of Q3 2025, which was down 1700.0% from 0.64% recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Return on Assets ranged from a high of 0.25% in Q2 2023 and a low of 0.64% during Q2 2025
  • For the 5-year period, Pliant Therapeutics' Return on Assets averaged around 0.41%, with its median value being 0.37% (2021).
  • In the last 5 years, Pliant Therapeutics' Return on Assets tumbled by -3000bps in 2021 and then soared by 3300bps in 2023.
  • Pliant Therapeutics' Return on Assets (Quarter) stood at 0.43% in 2021, then increased by 21bps to 0.34% in 2022, then rose by 10bps to 0.31% in 2023, then plummeted by -63bps to 0.5% in 2024, then fell by -22bps to 0.61% in 2025.
  • Its Return on Assets was 0.61% in Q3 2025, compared to 0.64% in Q2 2025 and 0.59% in Q1 2025.